Central Drug Standards Control Organisation
-
{
- All
- News
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Covid Vaccines Have Many Side-Effects? Centre Calls It "Erroneous Claim"
The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.
-
India Can Become A World Leader In Affordable Health Care: PM Modi
The Centre is committed to promoting traditional medicinal systems like Ayurveda which remain untapped due to inadequate scientific scrutiny and concerns regarding standards and quality, Prime Minister Narendra Modi said today.
-
India Adds More Cancer, HIV/AIDS Drugs To Essential Medicines List
The government has revised its list of essential medicines to add drugs for diseases ranging from cancer and HIV/AIDS to hepatitis C, in a move aimed at making them more affordable.
-
Green Panel Pulled Up Government for Failing to Conduct Study on Plastic Use
The National Green Tribunal today pulled up the government for failing to come up with a study on plastic packaging of products and generation of such municipal waste, saying the people should know whether its use is harmful.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
Covid Vaccines Have Many Side-Effects? Centre Calls It "Erroneous Claim"
The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.
-
India Can Become A World Leader In Affordable Health Care: PM Modi
The Centre is committed to promoting traditional medicinal systems like Ayurveda which remain untapped due to inadequate scientific scrutiny and concerns regarding standards and quality, Prime Minister Narendra Modi said today.
-
India Adds More Cancer, HIV/AIDS Drugs To Essential Medicines List
The government has revised its list of essential medicines to add drugs for diseases ranging from cancer and HIV/AIDS to hepatitis C, in a move aimed at making them more affordable.
-
Green Panel Pulled Up Government for Failing to Conduct Study on Plastic Use
The National Green Tribunal today pulled up the government for failing to come up with a study on plastic packaging of products and generation of such municipal waste, saying the people should know whether its use is harmful.
-
Probe finds 'alarming' problems with India's drug regulator
India's main drug regulator has not been properly scrutinising some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to circumvent procedure, according to a new parliamentary report. The report by parliament's health committee, the result of a more than year-long investigation, painted a chaot...
